MENU
INAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
IN8bio (INAB) Ownership - Who owns IN8bio?
Profile
Industry
N/A
Address
350 5th Avenue
Phone
+1 646 600-6438
Employees
31
Web
https://www.in8bio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
20.88M
P/E Ratio
N/A
Total Cash
4M
Projected Growth
N/A
Total Debt
5.47M
Revenue
N/A
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash/Share
0.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
INAB
Capitalization
20.9M
P/E Ratio
N/A
Risk (Beta)
-0.06
Dividend Yield
N/A
Total Cash
4M
Total Cash/Share
0.06
Total Debt
5.47M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
8.59M
P/B Ratio
2.43
Cash Flow
N/A
Earnings
-0.74
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
1.84
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-28.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-151.16
Shares Held By Institutions
4.69M
Shares Outstanding - Current
72.5M
Total Liabilities
7.38M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-79.130
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
350 5th Avenue
Phone
+1 646 600-6438
Employees
31
Web
https://www.in8bio.com